Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 24;60(1):20.
doi: 10.1186/s13028-018-0372-x.

Systemic inflammation in dogs with advanced-stage heart failure

Affiliations

Systemic inflammation in dogs with advanced-stage heart failure

Aleksandra Domanjko Petrič et al. Acta Vet Scand. .

Abstract

Background: Although human studies have shown that inflammation plays a role in the development of congestive heart failure, scarce information exists on white blood cell count (WBC) and differential cell counts in various stages of heart failure in man and dogs. A few studies demonstrated increased concentrations of C-reactive protein (CRP), a major acute-phase protein, in cardiac diseases in dogs. Our research aimed to investigate whether CRP concentration, WBC and neutrophil count (NEUT), as markers of systemic inflammation, are elevated in canine cardiovascular patients. We also aimed to find out whether there is an association between CRP concentration and WBC and NEUT, as well as associations between these inflammatory markers and selected echocardiographic parameters. Sixty-two client-owned canine cardiac patients and 12 healthy dogs were included in the study. The patients were classified into International Small Animal Cardiac Health Council classes (ISACHC I-III). The serum CRP concentration was determined using a canine CRP test kit. WBC and NEUT were determined using an automated hematology analyzer.

Results: Significantly higher serum CRP concentration, WBC and NEUT were found in the decompensated stage of heart failure (ISACHC III) compared with healthy dogs and with patients in ISACHC group II and ISACHC group I. Serum CRP concentration significantly positively correlated with WBC (r = 0.65, P < 0.001) and NEUT (r = 0.58, P = 0.002) in the ISACHC III group, while no significant correlations were found in the ISACHC I and II groups. A significant negative correlation between serum CRP concentration and the left ventricular ejection fraction (r = - 0.49, P = 0.046) and a significant positive correlation between CRP and the E wave velocity of the mitral valve inflow (r = 0.52, P = 0.046) were found in the ISACHC III group.

Conclusions: The CRP concentration, WBC and NEUT were significantly increased in advanced-stage heart failure patients in comparison with compensated patients and healthy dogs, which indicate the presence of systemic inflammation. However, normal CRP concentration and normal WBC and NEUT can also be present in heart failure.

Keywords: C-reactive protein; Congestive heart failure; Dogs; Leukocytes; Neutrophils.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Serum CRP concentrations in healthy dogs and groups of canine cardiac patients (ISACHC I–III). *significantly higher in comparison with ISACHC II (P < 0.001) and ISACHC I (P = 0.011) and healthy dogs (P = 0.001)
Fig. 2
Fig. 2
White blood cell count in healthy dogs and groups of canine cardiac patients (ISACHC I-III). *significantly higher in comparison with ISACHC II (P < 0.001) and ISACHC I (P = 0.004) and healthy dogs (P = 0.005)
Fig. 3
Fig. 3
Neutrophil count in healthy dogs and groups of canine cardiac patients (ISACHC I-III). *significantly higher in comparison with ISACHC II (P < 0.001) and ISACHC I (P = 0.003) and healthy dogs (P < 0.001)

References

    1. Boswood A. Biomarkers in cardiovascular disease: beyond natriuretic peptides. J Vet Cardiol. 2009;11:S23–S32. doi: 10.1016/j.jvc.2009.01.003. - DOI - PubMed
    1. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358:2148–2159. doi: 10.1056/NEJMra0800239. - DOI - PubMed
    1. Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM. 2003;96:793–807. doi: 10.1093/qjmed/hcg134. - DOI - PubMed
    1. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363–369. doi: 10.1161/01.CIR.0000053730.47739.3C. - DOI - PubMed
    1. Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62:397–408. doi: 10.1016/j.jacc.2013.05.016. - DOI - PubMed